Reeb Jeremie, Keshavjee Shaf, Cypel Marcelo
Division of Thoracic Surgery, Toronto Lung Transplant Program, University of Toronto Toronto Lung Transplant Program, Latner Thoracic Surgery Research Laboratories, Toronto, Ontario, Canada.
Curr Opin Organ Transplant. 2015 Oct;20(5):498-505. doi: 10.1097/MOT.0000000000000233.
The number of patients listed for lung transplantation largely exceeds the number of available transplantable organs because of a shortage of organ donors and a low utilization rate of lungs from those donors who are available. In recent years, novel strategies have been developed to increase the donor lung pool: improved donor management, the use of lungs from donations after cardiac death (DCD), the use of lobar lung living-donors (LLLD) and the use of ex-vivo lung perfusion (EVLP) to assess and repair injured donor lungs.
An adapted donor management strategy could expand the donor pool up to 20%. DCD lung transplant is an increasing part of the donor pool expansion. Outcomes after controlled DCD seem to be similar to donation after brain death. LLLD transplantation has excellent results for small and critically ill patients. EVLP treatment allows for a significant increase in the rate of suitable lungs and represents an optimal platform for lung reconditioning and specific lung therapies.
A significant increase in the number of available lungs for transplantation is expected in the future because of the wider use of lungs from controlled or uncontrolled DCD and LLLD lungs, and with organ-specific EVLP treatment strategies.
由于器官捐献者短缺以及可用捐献者的肺利用率低,等待肺移植的患者数量大大超过了可用于移植的器官数量。近年来,已开发出多种新策略来增加供肺库:改进供体管理、使用心脏死亡后捐献(DCD)的肺、使用活体肺叶供体(LLLD)以及使用体外肺灌注(EVLP)来评估和修复受损的供肺。
一种经过调整的供体管理策略可使供体库扩大达20%。DCD肺移植在扩大供体库方面所占比例日益增加。控制性DCD后的结果似乎与脑死亡后捐献相似。LLLD移植对小体型和重症患者效果极佳。EVLP治疗可显著提高合适肺的比例,是肺修复和特定肺治疗的理想平台。
由于更广泛地使用控制性或非控制性DCD的肺以及LLLD肺,并采用针对器官的EVLP治疗策略,预计未来可用于移植的肺数量将显著增加。